IP Lab Ventures
A Czech deep-tech venture builder and technology-transfer fund commercializing research-derived intellectual property.
Website: https://www.iplventures.com/
Cover Block
Publicly reported
| Field | Value |
|---|---|
| Name | IP Lab Ventures |
| Tagline | A Czech deep-tech venture builder and technology-transfer fund commercializing research-derived intellectual property. |
| Headquarters | Prague, Czech Republic [Crunchbase] |
| Founded | 2022 [Crunchbase] |
| Stage | Seed [CzechCrunch, September 2026] |
| Business Model | Other |
| Industry | Deeptech |
| Technology | Other |
| Geography | Eastern Europe |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) [CzechCrunch, September 2026] |
| Funding Label | Seed [CzechCrunch, September 2026] |
| Total Disclosed | CZK 656 million commitment from the European Investment Fund, with a fund target of approximately CZK 1.2 billion [CzechCrunch, September 2026] [Funds for NGOs, September 2026] |
Links
Publicly reported
- Website: https://www.iplventures.com/
Summary and Signal
PUBLIC IP Lab Ventures is a Prague-based venture builder and technology-transfer fund focused on turning research-derived intellectual property into venture-backable deep-tech companies, and it warrants attention now because its Fund I has secured a CZK 656 million commitment from the European Investment Fund against a target of roughly CZK 1.2 billion [CzechCrunch, September 2026] [Funds for NGOs, September 2026]. Public materials place the firm’s founding in 2022, with partners including Filip Fingl, Jiří Navrátil, and Andrew Hladký, while third-party reporting indicates the team spent several years assembling the platform before the EIF-backed fund close [Crunchbase] [CzechCrunch, September 2026] [David Swaim - Rockaway Capital | LinkedIn, 2026].
The operating model is more specific than a conventional seed fund: IP Lab says it selects defensible projects from universities and industry, tests the technology, team, and market case, and then helps form spin-offs with early commercialization support [iplventures.com] [e15, March 2026]. That company-building layer is the main point of differentiation in public sources, particularly in a region where academic research often reaches a financing gap before venture formation, customer discovery, and strategic partnership work are in place [iplventures.com] [CzechCrunch, September 2026].
On team quality, the public record is strongest around Fingl, whose profiles identify him as a founding partner or general partner and describe prior involvement in multiple spin-offs, including Preagon Biotech and MendelFOLD [Filip Fingl - General Partner at IP Lab Ventures - Igniting Deep Tech Revolution in CEE | LinkedIn, 2026] [Spin-Off Academy | LRMIPSM, 2026]. The evidence on broader team operating history is directionally positive but less settled, with some claims, including seven commercialized projects and the exact duration of prior collaboration, resting on lighter corroboration [Quasa, October 2026].
The business model appears to sit between fund management and venture creation: the firm raises institutional capital, then deploys it into research commercialization across areas such as AI, chips, robotics, cybersecurity, and other deep-tech domains cited in company and media sources [Martin Konecny - CRM & Customer Lifecycle Leader | Retention, Monetization & Segmentation | Churn Prevention | SaaS & Telecom | LinkedIn, 2026] [iplventures.com] [CzechCrunch, September 2026]. The near-term question is execution rather than positioning, specifically whether the team can convert this institutional backing into a repeatable pipeline of spin-offs, named portfolio outcomes, and evidence that the model scales across roughly 40 targeted projects, primarily in the Czech Republic [Martin Konecny - CRM & Customer Lifecycle Leader | Retention, Monetization & Segmentation | Churn Prevention | SaaS & Telecom | LinkedIn, 2026].
One source, partially checked -- Core fundraise facts are corroborated by CzechCrunch and Funds for NGOs, but several operating and team-history claims rely on company materials or LinkedIn-based sourcing.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Seed |
| Business Model | Other |
| Industry / Vertical | Deeptech |
| Technology Type | Other |
| Geography | Eastern Europe |
| Growth Profile | Venture Scale |
| Founding Team | Co-Founders (3+) |
| Funding | Seed |
Company Overview
PUBLIC
The public record on IP Lab Ventures is still thin, but the broad shape is clear. The firm presents itself as a Prague-based deep-tech venture builder and technology-transfer fund focused on commercializing research-derived intellectual property, with activity centered on Central and Eastern Europe [iplventures.com] [Crunchbase]. Crunchbase lists the organization as founded in 2022, which places it as a relatively new platform in institutional terms even if the underlying work of sourcing and shaping projects may have begun earlier [Crunchbase].
Its own website describes a model that starts upstream of a typical venture fund. IP Lab Ventures says it selects defensible projects from universities and industry, tests the technology, team, and market potential, and works to turn that intellectual property into venture-backed spin-offs [iplventures.com]. The same source frames the firm as supplying capital and commercialization support at the point where research teams often lack business development, early customer access, and venture-formation infrastructure [iplventures.com].
The clearest public milestone is the September 2026 disclosure that Fund I secured a CZK 656 million commitment from the European Investment Fund, with the vehicle targeting roughly CZK 1.2 billion in total according to public reporting [Crunchbase] [iplventures.com]. Taken together, that suggests IP Lab Ventures has moved from formation into fund assembly and external validation, though the available company and database sources do not establish a fuller chronology of portfolio launches or legal-entity detail.
One source, partially checked -- Confirmed in part by Crunchbase and the company website; chronology beyond founding year and broad operating model remains only partially corroborated.
The Product and the Stack
MIXED
IP Lab Ventures is not selling a single software product so much as a commercialization process. Public materials describe a venture builder and technology-transfer model that starts with selecting defensible research-derived projects from universities and industry, testing the underlying technology, team, and market potential, and then helping turn that intellectual property into venture-backed spin-offs [iplventures.com]. Press coverage in e15 describes the same sequence in plainer terms: find scientific or industrial ideas with commercial promise, add capital and business know-how, and work toward a company that can stand on its own in the market [e15.cz, March 2026].
The operating wedge appears to be hands-on formation support rather than passive fund capital. On its website, the firm says it fills the gap where academic research often lacks business development, early customer access, and venture-formation support, then helps projects secure initial customers, early revenue, and later strategic partners [iplventures.com]. Public reporting narrows the domain focus but not the technical implementation: the website lists areas including chemistry, materials science, advanced manufacturing, 3D printing, robotics, AI, autonomous systems, smart mobility, biotechnology, cybersecurity, and semiconductors, while later coverage and public LinkedIn posts emphasize AI, chips, robotics, autonomous systems, and cybersecurity as priority themes [iplventures.com] [cc.cz, September 2026] [linkedin.com, 2026].
That leaves the core product judgment fairly clear, even if the underlying workflow is only partly visible from outside. The investable asset here is a repeatable company-building system for research commercialization, not a disclosed platform stack, and no verified public demo or technical architecture detail surfaced in the cited materials [iplventures.com] [e15.cz, March 2026]. For investors, the key product question is therefore whether this process can reliably convert lab-stage IP into fundable companies across multiple domains, a claim the public sources frame as the mission but do not yet document with operating metrics or portfolio outcomes at scale [cc.cz, September 2026] [quasa.io, October 2026].
No independent source found -- This section relies materially on company website descriptions, with partial framing support from e15, CzechCrunch, and LinkedIn posts.
The Market They Are Entering
PUBLIC
The market matters now because IP Lab Ventures sits at the intersection of two funding priorities that have moved from policy language into funded mandates: European deep-tech commercialization and the conversion of university research into investable companies [CzechCrunch, September 2026] [Funds for NGOs, September 2026].
Public evidence is thin on formal market sizing, so the cleaner way to frame the addressable market is through the fund structure itself rather than an asserted TAM. IP Lab Ventures is targeting approximately CZK 1.2 billion for Fund I, with a CZK 656 million commitment from the European Investment Fund, or about €27 million according to separate coverage [CzechCrunch, September 2026] [Funds for NGOs, September 2026]. That does not size the full market for technology transfer in Central and Eastern Europe, but it does establish that a public institutional allocator believes the opportunity is large enough to anchor a dedicated vehicle in the Czech market [Funds for NGOs, September 2026] [EuropaWire, September 2026].
The immediate demand driver is visible in the problem statement repeated across sources. IP Lab Ventures says it is designed to fund and commercialize defensible projects from universities and industry, then help form spin-offs, win initial customers, and secure strategic partners once market validation begins [iplventures.com] [e15, March 2026]. That framing is company-supplied in part, but it aligns with outside reporting that describes the fund as a bridge between research output and company formation, especially in AI and other deep-tech fields where laboratory progress often outpaces business development capacity [CzechCrunch, September 2026] [Funds for NGOs, September 2026].
The adjacent markets are broader than classic venture capital. In practice, IP Lab Ventures appears to overlap with university technology transfer offices, venture builders, pre-seed deep-tech funds, and commercialization grants. Its reported focus areas, including AI, semiconductors, robotics, autonomous systems, cybersecurity, advanced manufacturing, and biotechnology, place it in markets where capital needs, validation cycles, and regulatory complexity are usually higher than in software-only startups [iplventures.com] [Martin Konecny - CRM & Customer Lifecycle Leader | Retention, Monetization & Segmentation | Churn Prevention | SaaS & Telecom | LinkedIn, 2026]. That matters because the substitute for a fund like this is often not another VC, but internal university transfer processes, public R&D financing, or ad hoc founder formation around a single lab asset.
Macro and policy forces are doing a meaningful share of the work here. The EIF commitment was reported as being supported by the Czech Ministry of Industry and Trade, and multiple outlets framed the vehicle as a first-of-its-kind Czech technology transfer fund, with one report tying that positioning specifically to AI applications [Ex-Dáme jídlo boss raises 656 million crowns for startups, 2026] [CzechCrunch, September 2026] [New Czech fund backs AI and deep-tech innovation with €50m for research commercialisation, 2026]. The practical implication is that this is not only a bottom-up market bet on spin-off creation, but also a top-down policy bet that the region needs institutional machinery to commercialize research more systematically.
| Cited sizing or market proxy | Figure | What it indicates |
|---|---|---|
| IP Lab Ventures Fund I target | CZK 1.2 billion | A public proxy for the initial capital pool aimed at Czech and CEE technology transfer [CzechCrunch, September 2026] |
| EIF commitment to Fund I | CZK 656 million | Institutional anchor capital validating the category in-market [CzechCrunch, September 2026] |
| EIF commitment to Fund I | €27 million | Same commitment reported in euro terms by a second source [Funds for NGOs, September 2026] |
| Supported projects targeted | Around 40 projects | A rough indicator of intended deployment breadth rather than market size [Martin Konecny - CRM & Customer Lifecycle Leader |
The table does not establish TAM, SAM, or SOM in the conventional sense, and it should not be read that way. It does show that the category already has a financed beachhead, with explicit institutional support and a stated plan to spread capital across a meaningful number of projects rather than a handful of flagship spin-outs [CzechCrunch, September 2026] [Funds for NGOs, September 2026].
One source, partially checked -- This section relies on two independent public reports for the fund target and EIF commitment, but broader market sizing and project-count evidence remain limited and partly company or LinkedIn sourced.
The Competitive Field
MIXED IP Lab Ventures is positioned less against a single direct startup rival than against three alternative routes for research commercialization in Central and Eastern Europe: university technology-transfer offices, conventional venture funds, and independent venture studios, each of which solves only part of the formation problem [iplventures.com] [e15, March 2026] [CzechCrunch, September 2026].
The competitive map is clearest when broken by function rather than by company. University and public-sector technology-transfer structures typically control early access to scientific output and institutional relationships, which makes them the incumbent gatekeepers for deal flow, but the public evidence here points to a gap in company formation, customer development, and venture packaging that IP Lab Ventures says it is designed to fill [iplventures.com] [e15, March 2026]. Conventional VC is the adjacent substitute: it can provide capital once a spin-off is legible as a fundable company, but the available reporting describes IP Lab Ventures as operating earlier, testing the technology, team, and market before that handoff exists [iplventures.com] [e15, March 2026].
A second layer of competition comes from generalist deep-tech investors and venture builders that could pursue similar assets once a project shows traction, even if none are named directly in the sourced record for this report. That matters because IP Lab Ventures is not claiming ownership of a narrow software channel; it is competing for the right to shape difficult science before other capital providers step in [CzechCrunch, September 2026] [e15, March 2026]. The description of the EIF-backed vehicle as the first fund of its kind in the Czech Republic suggests a temporary white space locally, but not a permanent moat if the model proves financeable [CzechCrunch, September 2026] [Funds for NGOs, September 2026].
Its edge today appears to rest on capital structure plus operating intent. The strongest public proof point is the CZK 656 million EIF commitment, reported as approximately €27 million, against a target fund size of about CZK 1.2 billion, which gives the platform institutional credibility that most ad hoc commercialization efforts do not have at formation [CzechCrunch, September 2026] [Funds for NGOs, September 2026]. The firm also presents itself as a venture builder rather than a passive allocator, with a stated role in securing early customers, validating market strategy, and forming spin-offs from defensible IP [iplventures.com] [e15, March 2026]. That edge is durable only if the team can keep proprietary access to university and research pipelines; otherwise, the capital signal is perishable, because later-stage investors can compete aggressively once the scientific and market risk have been reduced.
The exposure is just as specific. The current public record does not identify a broad installed network of portfolio companies, customer logos, or a named roster of private LPs beyond the EIF-backed commitment, which leaves IP Lab Ventures vulnerable to better-networked incumbents in university technology transfer and to conventional deep-tech funds once projects are de-risked [CzechCrunch, September 2026] [Quasa, October 2026]. The available sources also name no exclusive sourcing agreements with universities, so a material part of the competitive claim still depends on execution rather than on a contractual lock on distribution [Quasa, October 2026] [iplventures.com].
Over the next 18 months, the most plausible competitive scenario is not winner-take-all but specialization. IP Lab Ventures is the likely winner if the Czech market continues to reward structured pre-company commercialization, because the EIF-backed fund gives it a head start in assembling capital and process around that gap [CzechCrunch, September 2026] [Funds for NGOs, September 2026]. The most likely loser if universities strengthen in-house commercialization capacity or if generalist deep-tech funds move earlier is the fragmented, project-by-project transfer model inside existing institutional channels, not necessarily a named startup competitor, because that model appears least equipped to combine capital, venture formation, and customer discovery in one package [e15, March 2026] [iplventures.com].
Opportunity
Upside case
PUBLIC The prize here is not a single breakout startup, but a repeatable machine for turning under-monetized Czech and CEE research into venture-backed companies at enough volume to matter for an entire regional deep-tech ecosystem [CzechCrunch, September 2026] [e15, March 2026].
The headline opportunity is straightforward. If IP Lab Ventures can become the institution that universities, researchers, and industrial inventors call first when they have commercially promising IP, it could occupy a valuable control point between lab output and venture formation in a market that still appears structurally underserved [CzechCrunch, September 2026] [e15, March 2026]. That outcome looks reachable, rather than merely rhetorical, because the firm already has a large anchor commitment from the European Investment Fund, reported at CZK 656 million, or about €27 million, and is targeting roughly CZK 1.2 billion for Fund I [CzechCrunch, September 2026] [Funds for NGOs, September 2026]. Public reporting also describes the EIF-backed vehicle as the first fund of its kind in the Czech Republic, which matters less as branding than as evidence that there is white space for a specialized technology-transfer investor with a company-building model [CzechCrunch, September 2026].
That model is the part to watch. IP Lab Ventures says it does more than write checks: it selects defensible deep-tech projects from universities and industry, tests the technology, team, and market potential, and helps convert IP into venture-backed spin-offs while assisting with first customers and strategic partners [iplventures.com] [e15, March 2026]. If that process works even moderately well across dozens of projects, the firm is not simply another seed investor. It starts to resemble regional infrastructure for commercialization, with privileged access to technical deal flow before companies are fully formed [iplventures.com] [Martin Konecny - CRM & Customer Lifecycle Leader | Retention, Monetization & Segmentation | Churn Prevention | SaaS & Telecom | LinkedIn, 2026].
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Czech default for research commercialization | IP Lab Ventures becomes the go-to partner for universities and research teams that want to spin out commercially viable companies | The EIF-backed fund reaches enough scale to finance repeated spin-out formation across the Czech market | The fund is targeting about CZK 1.2 billion, already has a CZK 656 million EIF commitment, and is described as a first-of-its-kind Czech vehicle focused on this gap [CzechCrunch, September 2026] [Funds for NGOs, September 2026] |
| CEE deep-tech pipeline owner | The firm expands from the Czech base into a broader Central and Eastern European sourcing network and captures a disproportionate share of research-derived deep-tech formation in the region | Successful early spin-offs create proof that draws more university and founder partnerships across CEE | A partner profile describes the firm as a CEE deep-tech venture builder, and e15 frames the strategy as turning scientific ideas into globally competitive companies rather than serving a single local niche [LinkedIn] [e15, March 2026] |
| Specialized AI and hard-tech spin-out platform | IP Lab Ventures develops a reputation in a narrower set of high-value categories such as AI, semiconductors, robotics, and cybersecurity, where commercialization support is scarcer and technical diligence matters more | Concentrated category wins in sectors the fund already highlights publicly | Public materials and reporting consistently point to AI, chips, robotics, autonomous systems, and cybersecurity as target areas, which gives the firm a defined specialization rather than a generic innovation mandate [iplventures.com] [Martin Konecny - CRM & Customer Lifecycle Leader |
The compounding dynamic, if it emerges, is a sourcing and credibility flywheel. One successful spin-off does not just return capital, it also signals to universities, principal investigators, industrial labs, and co-investors that this team can move research across the awkward middle ground between grant-funded science and company formation [e15, March 2026] [iplventures.com]. That should improve access to earlier and better projects, which in turn improves selectivity. Public evidence of the flywheel is early rather than mature, but there are signs of the ingredients: the partners are reported to have worked together over multiple years, public profiles tie them to prior spin-off creation, and reporting says they have already built relationships with Czech universities and research organizations [Quasa, October 2026] [Spin-Off Academy | LRMIPSM, 2026] [David Swaim - Rockaway Capital | LinkedIn, 2026].
There is also a portfolio construction advantage embedded in the model. A fund aiming to support around 40 projects can tolerate the normal variance of deep-tech commercialization better than a studio built around only a handful of bets, provided it can keep formation costs disciplined and reserve enough follow-on capital for the winners [Martin Konecny - CRM & Customer Lifecycle Leader | Retention, Monetization & Segmentation | Churn Prevention | SaaS & Telecom | LinkedIn, 2026]. In practical terms, each additional university relationship, each repeatable diligence process, and each network of first customers or strategic partners should make the next spin-out easier to launch than the last [iplventures.com] [e15, March 2026].
The size of the win is necessarily scenario-based because there is no cited public market-sizing dataset in the source set. The cleaner way to frame it is at the platform level. If IP Lab Ventures becomes the institutional gateway for Czech, and eventually CEE, research commercialization, the asset could be worth far more than the economics of a conventional small seed fund because it would control scarce proprietary deal flow in categories such as AI, semiconductors, robotics, and biotech, backed by a first-mover position and state-supported credibility [CzechCrunch, September 2026] [iplventures.com]. A reasonable upside framing is that such a platform could evolve into the region's defining deep-tech venture builder and technology-transfer franchise, with value created across management fees, carry, and ownership stakes in the spin-offs it helps form (scenario, not a forecast) [e15, March 2026] [Funds for NGOs, September 2026]. The central point is not that the market is vaguely large. It is that a small number of institutions often mediate who gets funded, formed, and commercialized in fragmented ecosystems, and those control points can become durable if they are established early [CzechCrunch, September 2026] [Quasa, October 2026].
One source, partially checked -- This section relies on a mix of independent reporting from CzechCrunch, e15, Funds for NGOs, and Quasa, with some product-model details and category focus drawn from company and LinkedIn materials.
Sources
Publicly reported
[Crunchbase] IP Lab Ventures - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/ip-lab-ventures
[CzechCrunch, September 2026] Vláda posílá 700 milionů do nového druhu fondu, zaměří se i na AI, řídí ho bývalý šéf Dáme jídlo | https://cc.cz/vlada-posila-700-milionu-do-noveho-druhu-fondu-zameri-se-i-na-ai-ridi-ho-byvaly-sef-dame-jidlo/
[Funds for NGOs, September 2026] European Investment Fund backs first Czech IP Lab Ventures Fund I with €27m | https://news.fundsforngos.org/2026/09/28/eif-backs-czech-ai-tech-transfer-fund-ip-lab-ventures-27m/
[David Swaim - Rockaway Capital | LinkedIn, 2026] David Swaim - Rockaway Capital | LinkedIn | https://www.linkedin.com/in/david-swaim/
[iplventures.com] IP Lab Ventures | https://www.iplventures.com/
[e15, March 2026] IP Lab Ventures sází na deep tech. Z vědeckých nápadů chce budovat firmy světové úrovně | https://www.e15.cz/byznys/e15-a-byznys/ip-lab-ventures-sazi-na-deep-tech-z-vedeckych-napadu-chce-budovat-firmy-svetove-urovne-1431586
[Filip Fingl - General Partner at IP Lab Ventures - Igniting Deep Tech Revolution in CEE | LinkedIn, 2026] Filip Fingl - General Partner at IP Lab Ventures - Igniting Deep Tech Revolution in CEE | LinkedIn | https://www.linkedin.com/in/filip-fingl-414b7933/
[Spin-Off Academy | LRMIPSM, 2026] Filip Fingl - Spin-Off Academy | LRMIPSM | https://www.lrmipsm.cz/en/spin-off-academy/
[Quasa, October 2026] IP Lab Ventures Fund I: 656 milionů od EIF, cíl přes 1,2 miliardy | https://quasa.io/cs/media/stat-vlozil-656-milionu-do-transferu-vedy-fond-miri-na-12-miliardy
[Martin Konecny - CRM & Customer Lifecycle Leader | Retention, Monetization & Segmentation | Churn Prevention | SaaS & Telecom | LinkedIn, 2026] Martin Konecny - CRM & Customer Lifecycle Leader | Retention, Monetization & Segmentation | Churn Prevention | SaaS & Telecom | LinkedIn | https://www.linkedin.com/in/martin-konecny/
[EuropaWire, September 2026] EIF backs Czech IP Lab Ventures Fund I with €27 million to commercialise AI and deep-tech research | https://news.europawire.eu/eif-backs-czech-ip-lab-ventures-fund-i-with-e27-million-to-commercialise-ai-and-deep-tech-research/eu-press-release/2026/09/25/18/30/09/181385/
Articles about IP Lab Ventures
- IP Lab Ventures Lands a €27 Million Bet on Czech Deep-Tech — The European Investment Fund backed the first technology-transfer fund of its kind in the Czech Republic, aiming to turn research into 40 spin-offs.